Dr. Edward Boyle - Modeling and Validating: EcoJustifications for ERAS Cardiac Interventions ~ AATS

From the ERAS Cardiac Surgery Session (erascardiac.org) at the 2018 American Association of Thoracic Surgery Meeting on by Dr. Edward Boyle from the St. Charles Medical Center entitled: Modeling and Validating: Economic Justifications for ERAS Cardiac Interventions Using Real World Data.
The ERAS Cardiac Surgery mission is to optimize perioperative care of cardiac surgical patients through collaborative discovery, analysis, expert consensus, and dissemination of best practices.

ERAS Cardiac Surgery Treasurer and Process Lead for the ERACS Consensus Document
Ed Boyle, MD
Boyles Clinic
Bend, Oregon, USA
Edward Boyle, JR., MD
Boyles Clinic, Bend, Oregon, USA

Dr. Boyle's career spans clinical cardiothoracic surgery, surgical research and medical device innovation. He has received research awards from the American College of Surgeons, the American Heart Association, the Western Thoracic Surgery Association and the Seattle Surgical Society. He has received innovation awards from the European Association of Cardiothoracic Surgeons, the Gold Medical Design Excellence Award, ID Design Distinction, a Spark Award, and a Good Design Award. His work developing PleuraFlow was cited on the R&D 100 list, which salutes the 100 most technologically significant products introduced into the marketplace, the Innovations in Cardiovascular interventions (ICI) award and the Global Frost & Sullivan Award for New Product Innovation. He has authored over 90 peer-reviewed manuscripts and book chapters and is an inventor on over 20 US and international patents.

He was the founding CEO of ClearFlow, Inc., a venture financed medical device company that he led from inception through early commercialization before becoming Chairman. He was the founder of MDI Partners, a medical device incubator, and the President of Elixis, a healthcare information technology company that was acquired by Data Critical Corporation (NASDAQ: DCCA), now a division of General Electric (NYSE: GE). In this capacity he is experienced in taking ideas from the bedside through product approval and commercialization.

Dr. Boyle graduated from the University of Minnesota Medical School and completed general and cardiothoracic surgery training at the University of Washington in Seattle. In this setting he also completed a cardiovascular surgery research fellowship in vascular biology focusing on the study of inflammation and coagulation.